Literature DB >> 11906967

The atypical 5-HT2 receptor mediating tachycardia in pithed rats: pharmacological correlation with the 5-HT2A receptor subtype.

David Centurión1, Mario I Ortiz, Pramod R Saxena, Carlos M Villalón.   

Abstract

1. In pithed rats, 5-HT mediates tachycardia both directly (by 5-HT(2) receptors) and indirectly (by a tyramine-like effect). The receptor mediating tachycardia directly has been classified as an 'atypical' 5-HT(2) receptor since it was 'weakly' blocked by ketanserin. Moreover, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), a 5-HT(2) agonist, failed to mimic 5-HT-induced tachycardia. Since 5-HT(2) receptors consist of 5-HT(2A), 5-HT(2B) and 5-HT(2C) subtypes, this study investigated if these subtypes mediate the above response. 2. In pithed rats, intraperitoneally (i.p.) pre-treated with reserpine (5 mg kg(-1)), intravenous (i.v.) administration of 5-HT, 5-methoxytryptamine (5-MeO-T), 1-(3-chlorophenyl) piperazine (mCPP) and 5-carboxamidotryptamine (5-CT) (10, 30, 100 and 300 microg kg(-1) each), produced dose-dependent tachycardic responses. Interestingly, DOI (10 - 1000 microg kg(-1), i.v.) induced only slight, dose-unrelated, tachycardic responses, whilst the 5-HT(2C) agonist, Ro 60-0175 (10 - 1000 microg kg(-1), i.v.), produced a slight tachycardia only at 300 and 1000 microg kg(-1). In contrast, sumatriptan and 1-(m-trifluoromethylphenyl)- piperazine (TFMPP) were inactive. The rank order of potency was: 5-HT > or =5-MeO-T> mCPP > or =5-CT > or =DOI > Ro 60-0175. 3. The tachycardic responses to 5-HT, which remained unaffected after i.v. saline (0.3 and 1 ml kg(-1)) or propranolol (3 mg kg(-1)), were selectively blocked by the 5-HT(2A) antagonists ketanserin (30 and 100 microg kg(-1)) or spiperone (10 and 30 microg kg(-1)) as well as by the non-selective 5-HT(2) antagonists, ritanserin (10 and 30 microg kg(-1)) or mesulergine (100 microg kg(-1)). Remarkably, these responses were unaffected by the antagonists rauwolscine (5-HT(2B)), SB204741 (5-HT(2B/2C)) or Ro 04-6790 (5-ht(6)) (300 and 1000 microg kg(-1) each). 4. These results suggest that the 'atypical' 5-HT(2) receptors mediating tachycardia in reserpinized pithed rats are pharmacologically similar to the 5-HT(2A) receptor subtype.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11906967      PMCID: PMC1573258          DOI: 10.1038/sj.bjp.0704593

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist.

Authors:  D W Bonhaus; K K Weinhardt; M Taylor; A DeSouza; P M McNeeley; K Szczepanski; D J Fontana; J Trinh; C L Rocha; M W Dawson; L A Flippin; R M Eglen
Journal:  Neuropharmacology       Date:  1997 Apr-May       Impact factor: 5.250

2.  A pithed rat preparation suitable for assaying pressor substances.

Authors:  R E SHIPLEY; J H TILDEN
Journal:  Proc Soc Exp Biol Med       Date:  1947-04

3.  5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential.

Authors:  J R Martin; M Bös; F Jenck; J Moreau; V Mutel; A J Sleight; J Wichmann; J S Andrews; H H Berendsen; C L Broekkamp; G S Ruigt; C Köhler; A M Delft
Journal:  J Pharmacol Exp Ther       Date:  1998-08       Impact factor: 4.030

4.  Characterization of DOI, a putative 5-HT2 receptor agonist in the rat.

Authors:  H Dabiré; K Chaouche-Teyara; C Cherqui; B Fournier; M Laubie; H Schmitt
Journal:  Eur J Pharmacol       Date:  1989-09-22       Impact factor: 4.432

Review 5.  Cardiovascular effects of serotonin agonists and antagonists.

Authors:  P R Saxena; C M Villalón
Journal:  J Cardiovasc Pharmacol       Date:  1990       Impact factor: 3.105

Review 6.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

Authors:  D Hoyer; D E Clarke; J R Fozard; P R Hartig; G R Martin; E J Mylecharane; P R Saxena; P P Humphrey
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

7.  A comparison of cardiovascular and smooth muscle effects of 5-hydroxytryptamine and 5-carboxamidotryptamine, a selective agonist of 5-HT1 receptors.

Authors:  P R Saxena; A Lawang
Journal:  Arch Int Pharmacodyn Ther       Date:  1985-10

8.  Receptor-mediated effects of serotonin and 5-methoxytryptamine on noradrenaline release in the rat vena cava and in the heart of the pithed rat.

Authors:  M Göthert; E Schlicker; P Kollecker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-02       Impact factor: 3.000

9.  Characterization of Ro 04-6790 and Ro 63-0563: potent and selective antagonists at human and rat 5-HT6 receptors.

Authors:  A J Sleight; F G Boess; M Bös; B Levet-Trafit; C Riemer; A Bourson
Journal:  Br J Pharmacol       Date:  1998-06       Impact factor: 8.739

10.  5-Hydroxytryptamine receptors with a 5-HT6 receptor-like profile stimulating adenylyl cyclase activity in pig caudate membranes.

Authors:  P Schoeffter; C Waeber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-10       Impact factor: 3.000

View more
  8 in total

1.  Pharmacological profile of the 5-HT-induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: correlation with 5-HT1 and putative 5-ht5A/5B receptors.

Authors:  Araceli Sánchez-Lopez; David Centurión; Erika Vázquez; Udayasankar Arulmani; Pramod R Saxena; Carlos M Villalón
Journal:  Br J Pharmacol       Date:  2003-09-22       Impact factor: 8.739

2.  5-HT7 receptor efficacy distribution throughout the canine stomach.

Authors:  Pieter Janssen; Nicolaas H Prins; Pieter J Peeters; Klaas P Zuideveld; Romain A Lefebvre
Journal:  Br J Pharmacol       Date:  2004-08-31       Impact factor: 8.739

3.  L-Lysine acts like a partial serotonin receptor 4 antagonist and inhibits serotonin-mediated intestinal pathologies and anxiety in rats.

Authors:  Miro Smriga; Kunio Torii
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-15       Impact factor: 11.205

Review 4.  Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications.

Authors:  Carlos M Villalón; David Centurión
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-08-17       Impact factor: 3.000

5.  Presynaptic modulation of rat arterial chemoreceptor function by 5-HT: role of K+ channel inhibition via protein kinase C.

Authors:  Min Zhang; Ian M Fearon; Huijun Zhong; Colin A Nurse
Journal:  J Physiol       Date:  2003-06-25       Impact factor: 5.182

6.  Effect of peripheral 5-HT on glucose and lipid metabolism in wether sheep.

Authors:  Hitoshi Watanabe; Ryo Saito; Tatsuya Nakano; Hideyuki Takahashi; Yu Takahashi; Keisuke Sumiyoshi; Katsuyoshi Sato; Xiangning Chen; Natsumi Okada; Shunsuke Iwasaki; Dian W Harjanti; Natsumi Sekiguchi; Hiroaki Sano; Haruki Kitazawa; Michael T Rose; Shyuichi Ohwada; Kouichi Watanabe; Hisashi Aso
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

7.  The role of α1- and α2-adrenoceptor subtypes in the vasopressor responses induced by dihydroergotamine in ritanserin-pretreated pithed rats.

Authors:  Eduardo Rivera-Mancilla; Victor H Avilés-Rosas; Guadalupe Manrique-Maldonado; Alain H Altamirano-Espinoza; Belinda Villanueva-Castillo; Antoinette MaassenVanDenBrink; Carlos M Villalón
Journal:  J Headache Pain       Date:  2017-10-11       Impact factor: 7.277

Review 8.  Neurohumoral Control of Sinoatrial Node Activity and Heart Rate: Insight From Experimental Models and Findings From Humans.

Authors:  Eilidh A MacDonald; Robert A Rose; T Alexander Quinn
Journal:  Front Physiol       Date:  2020-03-03       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.